To quantify the strength and nature of the immune response to COVID-19 infection after recovery, the proposed serological tests will measure SARS-CoV-2-reactive IgG and IgM antibodies by rapidly adapt...
Vital Biosciences Inc.
20 records totalling $2,702,508.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $2,702,508 | 20 records |
Records
This project will cover the design and implementation of control systems to monitor the quality of reagents and various processes on our in vitro diagnostic platform. Having these systems in place wil...
In-house capability to produce two integrated microfluidic discs (Clinical Chemistry, Immunoassay) that meet required specifications and reproducibility.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
There are numerous biomarkers present at low concentrations whose detection can provide valuable information pertaining an individual's health. Examples include but are not limited to; (i) antigens de...
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
This project will result in a scalable manufacturing process for proprietary ion-selective sensors for the quantification of blood electrolytes.
In the proposed project, we will conduct a formal analysis of hazards and risks for our point-of-care diagostic platform. This comprehensive evaluation of potential failure modes will be the foundatio...
The proposed development of standardized quality control and fabrication protocols for our proprietary optical reporter particles will reduce batch variability and non-specific interactions, establish...
Reagent unitization and stabilization by lyophilization will enable the production of pre-dispensed and manipulatable reagents in assay cartridges that are shelf stable at room temperature. This will...
Clinical chemistry assays each come with different canonical protocols. Our goal is to reduce the large patient sample and reagent volumes required with traditional assay protocols, and run a large me...
This project will cover various verification and validation activities for prototype devices as Vital moves towards its first commercial launch.
This project will cover various process development activities for liquid and lyophilized reagents as Vital moves towards its first commercial launch.
This project will cover development activities for enhancing instrument prototype design as Vital moves towards its first commercial launch.
This project will cover various process development activities for liquid and lyophilized reagents as Vital moves towards its first commercial launch.
Hire of an Assay Development and Integration Technician.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
Support to enhance the Firm’s IP strategy
Participation in the Canadian Life Sciences co-innovation mission to Japan – October 6 to 10, 2025. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NR...